Oxular began a phase 2 trial for its therapeutic candidate OXU-001, for the treatment of diabetic macular edema in October ...

These resources include downloadable fact sheets, glaucoma financial assistance resources, shareable social media graphics, ...

The primary safety endpoint was carried out through the percentage of patients with shift from normal (at baseline) to ...